Ridgecrest Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Ridgecrest Wealth Partners's AMGN Position: Q1 2026 in Review
Ridgecrest Wealth Partners reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $17.8K and leaving 4,221 shares worth $1.49M. The position accounts for 0.82% of the portfolio, ranked #30.
Ridgecrest Wealth Partners first reported a position in AMGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.52M in Q1 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Ridgecrest Wealth Partners held 4,221 shares of Amgen worth $1.49M as of Q1 2026.
- Ridgecrest Wealth Partners sold 50 Amgen shares in Q1 2026, an estimated $17.8K.
- Amgen made up 0.82% of Ridgecrest Wealth Partners's portfolio in Q1 2026, its #30 holding.
- Ridgecrest Wealth Partners first reported a position in Amgen in Q1 2021 and has held it in 21 quarters since.
- Ridgecrest Wealth Partners's Amgen position peaked at $1.52M in Q1 2025.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Ridgecrest Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.